Last reviewed · How we verify
NCT03599180
Clinical Protocol of Sensitized Acupoint Changes in Knee Osteoarthritis Patients
trial testing microdialysis in Microdialysis in 33 participants. Completed in 1 February 2020.
30 September 2019
Quick facts
| Lead sponsor | Chinese Medical Association |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 33 |
| Start date | 1 June 2018 |
| Primary completion | 30 September 2019 |
| Estimated completion | 1 February 2020 |
| Sites | 1 location across China |
Drugs / interventions tested
- microdialysis
Conditions studied
- Microdialysis — all drugs for Microdialysis →
Sponsor
Chinese Medical Association
Who can join
Adults 38 to 70, any sex, with Microdialysis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Based on the research background and the preliminary research basis of the research group, in order to answer the material basis and micro-physical environment change characteristics of knee osteoarthritis sensitization acupoints and provide scientific basis for in-depth study of sensitization of acupoints. This study plans to use knee osteoarthritis as a research vehicle, and use microdialysis combined with high performance liquid chromatography to analyze the local material basis and key indicators of common sensitization points in knee osteoarthritis.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Metabolic profiling of dialysate at sensitized acupoints in knee osteoarthritis patients: A study protocol.
Li S, Chai XN, Zuo CY, Lv P, et al · · 2019 · cited 1× · PMID 31702640 · DOI 10.1097/md.0000000000017843
Verify or expand the search:
- PubMed search for NCT03599180
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of microdialysis
Trials testing the same drug.
- NCT03700346 — Muscle Lactate and Lactate to Pyruvate Ratio Clearance in Septic Shock Patients · NA · completed
Other Chinese Medical Association trials
Trials by the same sponsor.
- NCT07415473 — Akkermansia Muciniphila Combined With Infliximab for Promoting Intestinal Mucosal Healing in Crohn's Disease · Phase 4 · not yet recruiting
- NCT07417696 — Palmitoleic Acid Combined With Infliximab for Promoting Intestinal Mucosal Healing in Crohn's Disease · Phase 4 · not yet recruiting
- NCT05143593 — Species-specific Bacterial Detector for Fast Pathogen Diagnosis of Severe Pneumonia · NA · not yet recruiting
- NCT07037264 — A Study of the Efficacy and Safety of Non-ablative Fractional Laser in the Treatment of Thyroidectomy Scars · NA · enrolling by invitation
- NCT06850246 — Safety and Effectiveness of High Frequency Electrocautery for Abdominal Fat Reduction · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03599180 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chinese Medical Association
- Last refreshed: 12 February 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03599180.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing